全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Development of a high throughput screening assay for inhibitors of hedgehog-heparin interactions

DOI: http://dx.doi.org/10.2147/IJHTS.S7704

Keywords: hedgehog, heparin, fluorescence polarization, high throughput screening

Full-Text   Cite this paper   Add to My Lib

Abstract:

pment of a high throughput screening assay for inhibitors of hedgehog-heparin interactions Original Research (3267) Total Article Views Authors: Laura R Daye, Willietta Gibson, Kevin P Williams Published Date May 2010 Volume 2010:1 Pages 69 - 80 DOI: http://dx.doi.org/10.2147/IJHTS.S7704 Laura R Daye, Willietta Gibson, Kevin P Williams Department of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC , USA Abstract: The activity of hedgehog ligand is mediated in part by interactions with heparin and heparan sulfate proteoglycans. In order to identify inhibitors that block the interaction of hedgehog with heparin, we have developed a simple and robust high throughput assay based on fluorescence polarization. This assay utilizing fluorescein-labeled heparin binding to sonic hedgehog N-terminal domain (ShhN) protein was developed and optimized in a 384-well format. ShhN bound to fluorescein-labeled heparin with high affinity (KD = 99 nM) and the interaction was shown to be stable over time and tolerant to dimethyl sulfoxide (DMSO). A panel of unlabeled heparins of varying molecular weights was tested in the assay, with lower IC50 values correlating with heparins of increasing size. The assay was automated into two simple steps, and validation with whole DMSO plates yielded a Z’ factor of 0.56, indicating a robust assay for high throughput screening. We predict that this assay will be suitable for identifying chemical probes of hedgehog ligand-heparin interactions. Further, compounds that disrupt the ShhN interaction with heparin and/or heparan sulfate proteoglycans may be considered as potential therapeutics for those cancers driven by Hh ligand overexpression.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133